07:00 , Aug 25, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: WAS protein family member 3 (WASF3); NCK associated protein 1 (NCKAP1); cytoplasmic FMR1 interacting protein 1 (CYFIP1)

Cancer INDICATION: Breast cancer Patient sample, cell culture and mouse studies suggest that inhibiting the WASF3-NCKAP1-CYFIP1 complex could help treat metastatic breast cancer. In breast cancer patients, high tumor levels of NCKAP1 were associated with poor survival....
07:00 , Jun 25, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Epithelial cancer Cytoplasmic FMR1-interacting...